Next Article in Journal
Associations between Macronutrient Intakes and Obesity/Metabolic Risk Phenotypes: Findings of the Korean National Health and Nutrition Examination Survey
Next Article in Special Issue
Can Resveratrol Treatment Control the Progression of Induced Periodontal Disease? A Systematic Review and Meta-Analysis of Preclinical Studies
Previous Article in Journal
Differences and Similarities between Front-of-Pack Nutrition Labels in Europe: A Comparison of Functional and Visual Aspects
Open AccessReview

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology

Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(3), 627; https://doi.org/10.3390/nu11030627
Received: 23 February 2019 / Revised: 8 March 2019 / Accepted: 9 March 2019 / Published: 14 March 2019
(This article belongs to the Special Issue Resveratrol and Its Analogs in Human Diseases)
Cardio-oncology is a clinical/scientific discipline which aims to prevent and/or treat cardiovascular diseases in cancer patients. Although a large number of cancer treatments are known to cause cardiovascular toxicity, they are still widely used because they are highly effective. Unfortunately, therapeutic interventions to prevent and/or treat cancer treatment-induced cardiovascular toxicity have not been established yet. A major challenge for such interventions is to protect the cardiovascular system without compromising the therapeutic benefit of anticancer medications. Intriguingly, the polyphenolic natural compound resveratrol and its analogs have been shown in preclinical studies to protect against cancer treatment-induced cardiovascular toxicity. They have also been shown to possess significant anticancer properties on their own, and to enhance the anticancer effect of other cancer treatments. Thus, they hold significant promise to protect the cardiovascular system and fight the cancer at the same time. In this review, we will discuss the current knowledge regarding the cardio-protective and the anticancer properties of resveratrol and its analogs. Thereafter, we will discuss the challenges that face the clinical application of these agents. To conclude, we will highlight important gaps of knowledge and future research directions to accelerate the translation of these exciting preclinical findings to cancer patient care. View Full-Text
Keywords: resveratrol; cardio-oncology; cancer; cardiovascular; anthracycline; cardiotoxicity resveratrol; cardio-oncology; cancer; cardiovascular; anthracycline; cardiotoxicity
Show Figures

Figure 1

MDPI and ACS Style

Abdelgawad, I.Y.; Grant, M.K.O.; Zordoky, B.N. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology. Nutrients 2019, 11, 627. https://doi.org/10.3390/nu11030627

AMA Style

Abdelgawad IY, Grant MKO, Zordoky BN. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology. Nutrients. 2019; 11(3):627. https://doi.org/10.3390/nu11030627

Chicago/Turabian Style

Abdelgawad, Ibrahim Y.; Grant, Marianne K.O.; Zordoky, Beshay N. 2019. "Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology" Nutrients 11, no. 3: 627. https://doi.org/10.3390/nu11030627

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop